Search ⌘K Get the kit

IGF-1 LR3

Long R3 Insulin-like Growth Factor 1

IGF-1 LR3 is a modified version of insulin-like growth factor 1. Normal IGF-1 has a half-life of about 15 minutes. The LR3 modification extends it to 20-30 hours. IGF-1 is the downstream growth signal that HGH produces via the liver. Using IGF-1 LR3 skips the HGH step entirely and delivers the growth signal directly. This makes it potent for muscle hypertrophy but also means you bypass all the regulatory feedback your body uses to keep IGF-1 in check. Side effects include hypoglycemia (IGF-1 lowers blood sugar), gut distension at high doses, and theoretical cancer risk from sustained IGF-1 elevation. This is a serious compound for experienced users.

IGF-1 LR3 Protocol

Dose: 20-50mcg per day | Frequency: Once daily, post-workout preferred | Cycle: 4-6 weeks on, 4 weeks off | Route: SubQ or IM (site-specific)

Reconstitution: 1mL bacteriostatic water per 1mg vial. Free reconstitution calculator.

Eat carbs within 30 minutes of dosing to prevent hypoglycemia. IGF-1 lowers blood sugar significantly. Post-workout timing takes advantage of the anabolic window. Do not use on an empty stomach.

IGF-1 LR3 Effects

IGF-1 LR3 Side Effects

IGF-1 LR3 Dosing by Use Case

ConditionDoseDurationNotes
Muscle hypertrophy (bodybuilding)20-50mcg SubQ or IM daily, post-workout4-6 weeks on, 4 weeks offThe primary use case. IGF-1 LR3 stimulates muscle growth directly through IGF-1 receptor activation. IM injection in the target muscle may enhance localized growth (debated). Always eat carbs around dosing. Hypoglycemia is the main acute risk.
Recovery enhancement20-30mcg SubQ daily4 weeksLower doses for recovery without aggressive muscle growth goals. IGF-1 supports tissue repair systemically. The extended half-life means you get sustained signaling throughout the day.

IGF-1 LR3 Results Timeline

Frequently Asked Questions About IGF-1 LR3

What is IGF-1 LR3?

IGF-1 LR3 (Long R3 Insulin-like Growth Factor 1) is a modified version of human IGF-1 with an extended half-life of 20-30 hours (vs ~15 minutes for native IGF-1). IGF-1 is the growth signal your liver produces when stimulated by growth hormone. LR3 skips the GH/liver step and delivers the growth signal directly. It is a research compound with no FDA approval.

What is the best IGF-1 LR3 dosage?

20-50mcg subcutaneously once daily. Post-workout timing is preferred. For a 1mg vial reconstituted with 1mL bacteriostatic water, 20mcg is 2 units and 50mcg is 5 units on a U-100 insulin syringe. Always eat carbs within 30 minutes of dosing. IGF-1 lowers blood sugar. Hypoglycemia on an empty stomach is a real risk.

What are the side effects of IGF-1 LR3?

Hypoglycemia (blood sugar crash) is the main acute risk. Eat carbs around your dose. Joint pain from water retention (15%), headache (10%), and gut distension at higher doses over longer cycles. Theoretical cancer risk from sustained IGF-1 elevation. This is not a beginner compound. The side effect profile is more serious than most peptides on this wiki.

IGF-1 LR3 vs HGH: what is the difference?

HGH stimulates your liver to produce IGF-1 (among other effects). IGF-1 LR3 IS the growth signal, delivered directly. HGH has broader effects: fat metabolism, sleep, skin, hair. IGF-1 LR3 is more targeted: muscle growth and tissue repair. HGH is slower-acting and systemic. IGF-1 LR3 is faster and more direct. HGH has decades of human data. IGF-1 LR3 has none.

How do you reconstitute IGF-1 LR3?

Add 1mL of bacteriostatic water to a 1mg vial. That gives you 1,000mcg per mL. For a 20mcg dose, draw 2 units on a U-100 insulin syringe. For 50mcg, draw 5 units. Swirl gently. Never shake. Refrigerate after reconstitution. Use within 3-4 weeks. IGF-1 LR3 is fragile. Keep cold.

Evidence

Early research. IGF-1 LR3 is a modified version of insulin-like growth factor 1 with a longer half-life (~20-30 hours vs ~15 minutes for native IGF-1). Used primarily in bodybuilding for muscle hypertrophy. No completed human clinical trials. The mechanism is well-understood from IGF-1 biology but the modified version is research-grade only.

Approval status: Not approved

References

  1. Tomas FM, Knowles SE, Owens PC, et al. Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. Biochem J, 1993. PMID 8507693
  2. Francis GL, Ross M, Ballard FJ, et al. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. J Mol Endocrinol, 1992. PMID 1384701
  3. Philippou A, Halapas A, Maridaki M, et al. Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy. J Musculoskelet Neuronal Interact, 2007. PMID 18094500
  4. Barton ER. The ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair. Appl Physiol Nutr Metab, 2006. PMID 17213878

Storage

These statements have not been evaluated by the FDA. This content is for educational purposes only. Consult a healthcare professional before starting any protocol. vialprep sells injection supplies, not compounds.

·

Cadence
Route
Cycle
Evidence
Updated

What people say it does for them.

Potential side effects.

The numbers people actually run.

Reported dose
Frequency
Cycle length
Reconstitution
the move
Open in calculator

How it compares.

All head-to-heads →

Before you buy

Make the supplier show you
A batch-specific COA from a third-party lab
HPLC purity and mass spec matching the label
Endotoxin and sterility results
A lot number on the vial that matches the paperwork
How to read a COA →

Which Breaking Bad character is your supplier?

Check your source

Once it's in the fridge.

Evidence

Tier

Approval:

The research.

Disclaimer

This page is a community reference, not medical advice. Content reflects what users report, not clinical recommendations. Nothing here is approved for human use unless specifically noted. Always consult a healthcare professional before starting any protocol. vialprep sells injection supplies, not compounds.

Glance